Literature DB >> 16686428

Regulation of HIF: asparaginyl hydroxylation.

Daniel Peet1, Sarah Linke.   

Abstract

The hypoxia inducible transcription factors (HIFs) are regulated at the level of protein stability and transcriptional activity in an oxygen-dependent manner by prolyl and asparaginyl hydroxylation, respectively. Factor inhibiting HIF (FIH-1) is the only known HIF asparaginyl hydroxylase, and targets a conserved asparaginyl residue within the C-terminal activation domain (CAD) of HIF-alpha. This represses HIF-mediated transcription by inhibiting the recruitment of p300/CBP coactivators. Recent studies have demonstrated that the function of FIH-1 relative to the HIF prolyl hydroxylases (PHDs) is not redundant, and indicate that FIH-1 is a direct oxygen sensor. This paper will address recent published and unpublished work characterising the role of asparaginyl hydroxylation in the cellular response to hypoxia. The relative oxygen affinities and hypoxic activities of FIH-1 and the PHDs will be discussed. Furthermore, in vitro and cell-based assays demonstrating some novel characteristics regarding the substrate specificity of FIH-1, and their potential biological and therapeutic relevance will be presented.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16686428

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  9 in total

Review 1.  Cancer nanomedicines targeting tumor extracellular pH.

Authors:  Li Tian; You Han Bae
Journal:  Colloids Surf B Biointerfaces       Date:  2011-10-25       Impact factor: 5.268

Review 2.  Signal transduction in vasculogenesis and developmental angiogenesis.

Authors:  Sunita Patel-Hett; Patricia A D'Amore
Journal:  Int J Dev Biol       Date:  2011       Impact factor: 2.203

Review 3.  A therapeutic role for targeting c-Myc/Hif-1-dependent signaling pathways.

Authors:  Klaus Podar; Kenneth C Anderson
Journal:  Cell Cycle       Date:  2010-05-01       Impact factor: 4.534

4.  Comparison of the Hydroxylase Inhibitor Dimethyloxalylglycine and the Iron Chelator Deferoxamine in Diabetic and Aged Wound Healing.

Authors:  Dominik Duscher; Michael Januszyk; Zeshaan N Maan; Alexander J Whittam; Michael S Hu; Graham G Walmsley; Yixiao Dong; Sacha M Khong; Michael T Longaker; Geoffrey C Gurtner
Journal:  Plast Reconstr Surg       Date:  2017-03       Impact factor: 4.730

Review 5.  NF-κB and HIF crosstalk in immune responses.

Authors:  Laura D'Ignazio; Daniel Bandarra; Sonia Rocha
Journal:  FEBS J       Date:  2015-11-24       Impact factor: 5.542

6.  HIF1/2α mediates hypoxia-induced LDHA expression in human pancreatic cancer cells.

Authors:  Xin-Gang Cui; Zhi-Tao Han; Shao-Hui He; Xing-da Wu; Tian-Rui Chen; Cheng-Hao Shao; Dan-Lei Chen; Ning Su; Yuan-Ming Chen; Ting Wang; Jing Wang; Dian-Wen Song; Wang-Jun Yan; Xing-Hai Yang; Tielong Liu; Hai-Feng Wei; Jianru Xiao
Journal:  Oncotarget       Date:  2017-04-11

Review 7.  Modulation of TRP Channel Activity by Hydroxylation and Its Therapeutic Potential.

Authors:  Yagnesh Nagarajan; Grigori Y Rychkov; Daniel J Peet
Journal:  Pharmaceuticals (Basel)       Date:  2017-03-27

Review 8.  Regulatory mechanism of HIF-1α and its role in liver diseases: a narrative review.

Authors:  Qingfei Chu; Xinyu Gu; Qiuxian Zheng; Haihong Zhu
Journal:  Ann Transl Med       Date:  2022-01

Review 9.  Systems approaches to understand oxygen sensing: how multi-omics has driven advances in understanding oxygen-based signalling.

Authors:  Michael Batie; Niall S Kenneth; Sonia Rocha
Journal:  Biochem J       Date:  2022-02-11       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.